Circulating cytokines in relation to the extent and composition of coronary atherosclerosis: Results from the ATHEROREMO-IVUS study

Atherosclerosis

Volumn 236, Issue 1, 2014, Pages

  Battes, Linda C ^a   Cheng, Jin M ^a   Oemrawsingh, Rohit M ^a   Boersma, Eric ^a   Garcia Garcia, Hector M ^a   de Boer, Sanneke P M ^a   Buljubasic, Nermina ^a   Mieghem, Nicolas A van ^a   Regar, Evelyn ^a   Geuns, Robert Jan van ^a   Serruys, Patrick W ^a   Akkerhuis, K Martijn ^a   Kardys, Isabella ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Biomarker; Cytokine; Intravascular ultrasound

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL STUDY; CONCENTRATION (PARAMETERS); CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HISTOLOGY; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; VIRTUAL HISTOLOGY; AGED; ANGINA PECTORIS; BLOOD; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; INFLAMMATION; MULTICENTER STUDY; NETHERLANDS; PATHOLOGY; RADIOGRAPHY; RISK FACTOR;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NETHERLANDS; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84905855332     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.06.010     Document Type: Article

References (37)

1. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012 Sep, 32(9):2045-2051.
2. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 Apr 21, 352(16):1685-1695.
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999 Jan 14, 340(2):115-126.
4. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013 May 23, 368(21):2004-2013.
5. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006 Apr, 86(2):515-581.
6. Ait-Oufella H., Taleb S., Mallat Z., Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 2011 May, 31(5):969-979.
7. Hansson G.K., Robertson A.K., Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol 2006, 1:297-329.
8. Voloshyna I., Littlefield M.J., Reiss A.B. Atherosclerosis and interferon-gamma: New insights and therapeutic targets. Trends Cardiovasc Med 2014 Jan, 24(1):45-51.
9. de Boer S.P., Cheng J.M., Garcia-Garcia H.M., Oemrawsingh R.M., van Geuns R.J., Regar E., et al. Relation of genetic profile and novel circulating biomarkers with coronary plaque phenotype as determined by intravascular ultrasound: rationale and design of the ATHEROREMO-IVUS study. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2013 Aug 26, pii: 20130113-01.
10. Nair A., Margolis M.P., Kuban B.D., Vince D.G. Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2007 May, 3(1):113-120.
11. Rodriguez-Granillo G.A., Garcia-Garcia H.M., Mc Fadden E.P., Valgimigli M., Aoki J., de Feyter P., et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol 2005 Dec 6, 46(11):2038-2042.
12. Cheng J.M., Oemrawsingh R.M., Garcia-Garcia H.M., Akkerhuis K.M., Kardys I., de Boer S.P.M., et al. C-reactive protein in relation to coronary plaque burden and presence of high risk lesions on intravascular ultrasound and cardiovascular outcome: Results of the ATHEROREMO-IVUS study 2014, [submitted].
13. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 1999 Apr, 19(4):972-978.
14. Prasongsukarn K., Chaisri U., Chartburus P., Wetchabut K., Benjathummarak S., Khachansaksumet V., et al. Phenotypic alterations in human saphenous vein culture induced by tumor necrosis factor-alpha and lipoproteins: a preliminary development of an initial atherosclerotic plaque model. Lipids Health Dis 2013, 12(1):132.
15. Mizia-Stec K., Gasior Z., Zahorska-Markiewicz B., Janowska J., Szulc A., Jastrzebska-Maj E., et al. Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron Artery Dis [Comparative Study] 2003 Sep, 14(6):431-438.
16. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000 May 9, 101(18):2149-2153.
17. Valgimigli M., Ceconi C., Malagutti P., Merli E., Soukhomovskaia O., Francolini G., et al. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study. Circulation 2005 Feb 22, 111(7):863-870.
18. Naranjo A., Sokka T., Descalzo M.A., Calvo-Alen J., Horslev-Petersen K., Luukkainen R.K., et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis research & therapy 2008, 10(2):R30.
19. Cherneva Z.V., Denchev S.V., Gospodinova M.V., Cakova A., Cherneva R.V. Inflammatory cytokines at admission-independent prognostic markers in patients with acute coronary syndrome and hyperglycaemia. Acute Card Care 2012 Mar, 14(1):13-19.
20. Sukhija R., Fahdi I., Garza L., Fink L., Scott M., Aude W., et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol 2007 Apr 1, 99(7):879-884.
21. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., et al. Protective role of interleukin-10 in atherosclerosis. Circulation Res [Research Support, Non-U.S. Gov't] 1999 Oct 15, 85(8):e17-24.
22. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Boersma E., Simoons M.L., et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003 Apr 29, 107(16):2109-2114.
23. Welsh P., Murray H.M., Ford I., Trompet S., de Craen A.J., Jukema J.W., et al. Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk. Arteriosclerosis. Thromb Vasc Biol 2011 Oct, 31(10):2338-2344.
24. Oemrawsingh R.M., Lenderink T., Akkerhuis K.M., Heeschen C., Baldus S., Fichtlscherer S., et al. Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome. Heart 2011 Jul, 97(13):1061-1066.
25. Chang L.T., Yuen C.M., Sun C.K., Wu C.J., Sheu J.J., Chua S., et al. Role of stromal cell-derived factor-1alpha, level and value of circulating interleukin-10 and endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty. Circ J 2009 Jun, 73(6):1097-1104.
26. Yip H.K., Youssef A.A., Chang L.T., Yang C.H., Sheu J.J., Chua S., et al. Association of interleukin-10 level with increased 30-day mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Circ J 2007 Jul, 71(7):1086-1091.
27. Anguera I., Miranda-Guardiola F., Bosch X., Filella X., Sitges M., Marin J.L., et al. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am Heart J 2002 Nov, 144(5):811-817.
28. Chaturvedi A.K., Kemp T.J., Pfeiffer R.M., Biancotto A., Williams M., Munuo S., et al. Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. Cancer Epidemiol Biomarkers Prev 2011 Sep, 20(9):1902-1911.
29. Soares H.D., Chen Y., Sabbagh M., Roher A., Schrijvers E., Breteler M. Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels. Ann N Y Acad Sci 2009 Oct, 1180:56-67.
30. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000 Apr 18, 101(15):1767-1772.
31. Rosso R., Roth A., Herz I., Miller H., Keren G., George J. Serum levels of interleukin-18 in patients with stable and unstable angina pectoris. Int J Cardiol 2005 Jan, 98(1):45-48.
32. Hulthe J., McPheat W., Samnegard A., Tornvall P., Hamsten A., Eriksson P. Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis 2006 Oct, 188(2):450-454.
33. Cheng J.M., Garcia-Garcia H.M., de Boer S.P., Kardys I., Heo J.H., Akkerhuis K.M., et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J 2014 Mar, 35(10):639-647.
34. Nicholls S.J., Hsu A., Wolski K., Hu B., Bayturan O., Lavoie A., et al. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol [Research Support, Non-U.S. Gov't] 2010 May 25, 55(21):2399-2407.
35. Puri R., Nissen S.E., Shao M., Ballantyne C.M., Barter P.J., Chapman M.J., et al. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy. Eur Heart J 2013 Nov, 34(41):3182-3190.
36. Garcia-Garcia H.M., Costa M.A., Serruys P.W. Imaging of coronary atherosclerosis: intravascular ultrasound. Eur Heart J 2010 Oct, 31(20):2456-2469.
37. Virmani R. Are our tools for the identification of TCFA ready and do we know them?. JACC Cardiovasc imaging 2011 Jun, 4(6):656-658. [Comment Editorial].